MedKoo Cat#: 112187 | Name: SABRAC
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SABRAC inhibits acid ceramidase in PC3 MC metastatic prostate cancer cells (IC50 = <1 µM), as well as induces accumulation of ceramides in the same cells.

Chemical Structure

SABRAC
SABRAC
CAS#886212-98-2

Theoretical Analysis

MedKoo Cat#: 112187

Name: SABRAC

CAS#: 886212-98-2

Chemical Formula: C20H40BrNO3

Exact Mass: 421.2192

Molecular Weight: 422.45

Elemental Analysis: C, 56.86; H, 9.54; Br, 18.91; N, 3.32; O, 11.36

Price and Availability

Size Price Availability Quantity
1mg USD 260.00 2 Weeks
5mg USD 580.00 2 Weeks
10mg USD 910.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SABRAC
IUPAC/Chemical Name
2-bromo-N-((2S,3R)-1,3-dihydroxyoctadecan-2-yl)acetamide
InChi Key
KXLZSKTVZMRRCY-RBUKOAKNSA-N
InChi Code
InChI=1S/C20H40BrNO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(24)18(17-23)22-20(25)16-21/h18-19,23-24H,2-17H2,1H3,(H,22,25)/t18-,19+/m0/s1
SMILES Code
BrCC(N[C@H]([C@H](O)CCCCCCCCCCCCCCC)CO)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 422.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Ordóñez YF, Abad JL, Aseeri M, Casas J, Garcia V, Casasampere M, Schuchman EH, Levade T, Delgado A, Triola G, Fabrias G. Activity-Based Imaging of Acid Ceramidase in Living Cells. J Am Chem Soc. 2019 May 15;141(19):7736-7742. doi: 10.1021/jacs.8b11687. Epub 2019 May 2. PMID: 31030513. Muley H, Dowdy T, Zaibaq F, Karadimov G, Li A, Song H, Zhang M, Zhang W, Wong Z, Zhang L, Lita A, Larion M. Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors. bioRxiv [Preprint]. 2024 Apr 29:2024.04.27.591426. doi: 10.1101/2024.04.27.591426. PMID: 38903086; PMCID: PMC11188094.